Humacyte, Inc.
USD1.40
+0.01 (+0.72%)
CEO
Laura E. Niklason
IPO Date
2020-12-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.42
Prev. Close
$1.39
Day Low
$1.35
Day High
$1.46
52W Low
$0.55
52W High
$2.93
Market Cap
$0.24B
Volume
5.48M
| 11,000 |
| $0.89 |
| 20 May 2026 | Sander Dale A. | CFO and Chief Corp. Dev. Off | S-Sale | Disposed | 45,887 | $0.90 |
| 20 May 2026 | Parikh Shamik J | Chief Medical Officer | S-Sale | Disposed | 45,887 | $0.90 |
| 8 Dec 2025 | FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ | — | Disposed | 0 | $0.00 |
| 17 Nov 2025 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | A-Award | Acquired | 311,100 | $0.00 |
| 17 Nov 2025 | Parikh Shamik J | Chief Medical Officer | A-Award | Acquired | 311,100 | $0.00 |
| 17 Nov 2025 | Dougan Brady W | director | A-Award | Acquired | 311,100 | $1.23 |
| 17 Nov 2025 | Niklason Laura E | director, officer: President, CEO and Director | A-Award | Acquired | 311,100 | $1.23 |
| 20 Aug 2025 | Dougan Brady W | director | S-Sale | Disposed | 549,360 | $1.83 |
| $1,001 - $15,000 |
| 13 Jun 2024 | Tommy Tuberville | Tommy Tuberville | Sale (Partial) | $15,001 - $50,000 |
| 15 May 2024 | Tommy Tuberville | Tommy Tuberville | Sale (Partial) | $50,001 - $100,000 |
| 14 May 2024 | Tommy Tuberville | Tommy Tuberville | Sale (Partial) | $50,001 - $100,000 |
| 15 Apr 2024 | Tommy Tuberville | Tommy Tuberville | Purchase | $15,001 - $50,000 |
| 14 Apr 2024 | Tommy Tuberville | Tommy Tuberville | Purchase | $15,001 - $50,000 |
| 15 Mar 2024 | Tommy Tuberville | Tommy Tuberville | Purchase | $15,001 - $50,000 |
| 14 Mar 2024 | Tommy Tuberville | Tommy Tuberville | Purchase | $15,001 - $50,000 |